Crossmark

Letter: Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial

Published Online: 2025-02-26

Published Print: 2025-06

Authors

Dalai, Motij Kumar

Chandnani, Sanjay Jagdish https://orcid.org/0000-0001-8270-7680
License Information

Text and Data Mining valid from 2025-02-26

Version of Record valid from 2025-02-26
More Information

Article History

Received: 7 February 2025

Accepted: 10 February 2025

First Online: 26 February 2025

Declarations

:

: Authors Dr.Motij Kumar Dalai and Dr Sanjay Chandnani have no conflicts of interest.

Document is current